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Introduction
Möbius syndrome (MS) was described in 1888. It is charac-
terized by the feeling of wearing a face mask, and it involves
the sixth and seventh cranial nerves. Necropsies showed
some causes for this problem: hypoplasia or absence of
central brain nuclei, destructive degeneration of central brain
nuclei, peripheral nerve involvement, and myopathy. This
disease may be associated with other cranial and musculo-
skeletal anomalies.1–3
Studies document that a paresis or paralysis of the seventh
cranial nerve can be accompanied by paralysis of many other
pairs of nerves. Because of changes to organs that form
between 23 and 46 days of embryonic life, a common factor
might affect all these structures. The most accepted hypothe-
sis is that of a disruption of the vascular system or other
mechanisms such as hemorrhage, thrombosis, or stenosis
involving veins of the second pharyngeal arch, facial arteries,
and the absence of triplet formation of the vertebral basilar
system affect the development of the core cranial nerves.
The disease occurs sporadically, but it can occur in the
same family.4 The genetics may be autosomal dominant or
autosomal recessive, and X-linked recessive cytogenetic stud-
ies show its location on chromosome 13, loci on 3q21–q22
and 10q21.3–q22.1. Causes cited are also teratogenic,5–8 and
these are apparently the most common in Brazil. Misoprostol
(synthetic analog of natural prostaglandin E1; Cytotec, Pﬁzer,
Connecticut, USA) has been used orally and vaginally in the
ﬁrst months of pregnancy in an attempt to interrupt it.
Studies suggest that there is a strong association between
attempted abortion with misoprostol and the subsequent
birth of individuals with MS. Misoprostol can also be used
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Abstract Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has
a great frequency because of the use of misoprostol during pregnancy.
Objective Verify if the speech and language performance of children with MS whose
mothers reported use of misoprostol (Cytotec, Pﬁzer, Connecticut, USA) are different
from the performance of children of mothers who did not report use.
Methods The stomatognathic system beyond receptive and expressive language and
speech was evaluated in children with MS, and their mothers were questioned whether
they used misoprostol during the pregnancy.
Results During the interview, 61.11% of mothers reported that they took misoprostol
during the pregnancy. Most of the subjects (83.3%) whose mothers took misoprostol
presented bilateral palsy beyond bad mobility of the tongue (90.9%) and speech
disorders (63.6%).
Conclusion The number of mothers who took misoprostol without knowing the risk
for MS was great. The lack of facial expressions and speech disorders were common
characteristics of the individuals with MS, whether the mothers tookmisoprostol during
the pregnancy or not.
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to decrease the blood ﬂow in gastric ulcers, which in our
population corresponded to 11 mothers (61.1%).
Both the location of anomalies and their severity vary from
patient to patient, and a systematic study needs to be
performed to recognize more clearly the pathogenesis of
the disease.9,10 We have found individuals with cleft palate
andmicrognathia-associated congenital clubfeet and changes
in IX, X, XI and XII cranial nerves, similar to the authors
mentioned previously. Such anomalies disrupt stomatog-
nathic functions of sucking, chewing, swallowing, and speech
and can slow the patient’s motor development.
According to some researchers,7 the pathophysiology of
this disease begins in infancy, but its manifestations occur
until the birth stage. Becauseboth soft tissues and bone can be
affected, these individuals require multidisciplinary treat-
ment throughout development to adulthood.
The childwithMS has difﬁculty sucking and swallowing at
birth and requires speech therapy for speciﬁc training. Often
associated with this difﬁculty is mandibular hypoplasia and
retrognathia,11 which can change the shape and mobility of
the tongue. When oral feeding is considered impossible,
gastrostomy should be indicated.
Another manifestation present at birth is the inability to
close themouth, which favors drooling, as the deﬁcit prevents
the ejection of saliva into the pharynx.
Lack of facial expression (crying, laughing) hinders com-
munication with the child’s mother in the ﬁrst few months,
and she is not able to identify if the sounds made by the baby
are related to pain or pleasure.
Eye occlusion is also altered,8 requiring eye care to prevent
drying of the cornea, as the child is also unable to blink.
Convergent strabismus is also present and requires corrective
surgery in a timely manner.
When the cranial nerves (IX, X, XII, and XII) are also
affected,10 children have difﬁculty swallowing, and they
lack of velopharyngeal sphincter closing and laryngeal inco-
ordination. Speech will also be affected,12,13 requiring speech
therapy to produce phonemes, which often requires compen-
satory procedures.
The clubfoot should be evaluated by an orthopedist,6 who
will decide on surgical need. The delay in this correction will
interfere with the patient’s motor development. Other anom-
alies may occur in the upper extremities, such as polydactyly,
syndactyly, and artrogriposis. These should also be evaluated,
and the appropriate course of action should be performed in
the shortest possible time so as not to jeopardize the devel-
opment of this child.
The congenital facial palsy usually originates in the em-
bryonic stage, and it is not known how to make these nerves
become normal.2 Thus, the surgical resources should only be
offered to the patient when he/she is a teenager, as the
surgery will not change the face to the normal aspect, neither
adequate the functions.
As previously mentioned, in Brazil, the use of misoprostol
was the most common cause of MS. In our institution since
1989, a large number of mothers reported on their use of the
drug. We investigated whether there were differences in the
manifestations of these individuals with MS, depending on
the etiology of the disease: teratogenic or otherwise. There-
fore, we describe the conditions of individuals with MS
treated at our institution whose mothers and/or caregivers
reported on the use of misoprostol during pregnancy to see if
the disease manifested differently.
Methods
A total of 18 females and males, aged from 4 months to
10 years, with a previous diagnosis of MS between Au-
gust 2008 and December 2009 came to our hospital. They
were from different areas and received evaluation and/or
counseling. Many were referred by health professionals or
through theWeb site that addresses the topic, available on the
homepage of this institution. The inclusion criterion for our
study was the previous diagnosis of MS. The exclusion
criterion was different diseases from MS.
Mothers and/or guardians of these individuals gave case
histories, and the patients reviewed the stomatognathic
system and understanding and expression of language con-
tained in the protocol used in this sector.14 Data were
recorded for statistical analysis.
The assessment and interview protocols followed for the
exclusive care of patients bornwithMS used in the institution
have been published,14 and they cover information on speech,
language, voice, and stomatognathic system (structures and
functions), including questions about identiﬁcation, history,
pregnancy, delivery, and development of the individual, as
well as information regarding the use of abortive or other
drugs.15
In our institution, data concerning the individuals re-
corded in medical records can be used for research purposes,
provided that the patient’s identity is kept conﬁdential and
that consent is given prior to application of the procedures
(CEP 1038/10 Ethics and Research Commission from the
Institution).
►Table 1 shows the individuals’ sex and age.
All data taken from the records and the different manifes-
tations were analyzed independently or in relation to each
other, according to the hypotheses of whether mothers who
had taken misoprostol could cause worsened disease.
We used testing equality of two ratios, chi-square for
independence, and conﬁdence intervals for the mean; a p
value of 0.05 (5%) was considered signiﬁcant.
Results
The subjects came from different localities and institutions
seeking guidance or evaluation and clinical care. Some were
from other cities or already receiving some form of speech
Table 1 Gender distribution for the overall sample
Gender n % p value
Female 7 38.9 0.182
Male 11 61.1
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therapy. Those from other cities often requested continuation
of therapy procedures at home. Some professionals (speech
therapists, physiotherapists, nurses) accompanied the visit-
ing families. The demographic proﬁling of this populationwas
not a focus of this research.15
Of the mothers, 61.1% admitted taking the drug Cytotec at
some time during pregnancy, usually in the ﬁrst few weeks;
others denied use or were evasive. Such data were not
statistically signiﬁcant. Only one grandmother said that
during pregnancy her daughter used “hard drugs” (concomi-
tant use of teratogenic drugs).
Speciﬁc evidence described by participants most com-
monly referred to facial movements. We found that most
had paralysis on both sides of the face. As for the other events
mentioned in the literature, such as changes in the hands,
feet, cleft palate, and strabismus requiring surgical correction,
the results were as follows: no subject had abnormal hands;
some individuals had clubfoot but had reconstructive sur-
gery; others had convergent strabismus and also had speciﬁc
treatment (surgery and/or use of buffer); and others had
palatoplasty. Some mothers reported complications during
pregnancy such as hypertension and diabetes, and some
patients were born prematurely.
Most subjects showed no otorhinolaryngologic changes.
Fewcentral nervous system changesweremanifested, such as
seizure disorders and vascular calciﬁcation. Although the
most common manifestation related to food and speech,
somemothers complained that their children presented little
understanding of speech.
Almost half of the individuals had not yet established
speech or speech was delayed for their age. Many showed
enough tongue mobility for swallowing and speech. Few
showed changes compatiblewith thedisease, as the realization
of bilabial consonants articulation at other places but the lips
and difﬁculty achieving the apical tongue sounds (paralysis of
the orbicular muscles of the mouth and tongue paresis).
Most individuals regularly attended classes in basic
schools and a few were too young to attend or their parents
did not think it was convenient to put them in daycare centers
or preschools (►Table 2).
Data from these subjects were evaluated separately to
study the hypothesis that misoprostol taken during
Table 2 Distribution of data for overall sample
Overall No Yes p value
n % n %
Amb 15 83.3 3 16.7 <0.001a
ADL 7 38.9 11 61.1 0.182
Hand Sur 18 100.0 0 0 <0.001a
Eye Sur 15 83.3 3 16.7 <0.001a
Palate Sur 14 77.8 4 22.2 <0.001a
Foot Sur 13 72.2 5 27.8 0.008a
Misoprostol 7 38.9 11 61.1 0.182
Under 12 66.7 6 33.3 0.046a
Drugs 17 94.4 1 5.6 <0.001a
Emiss 7 38.9 11 61.1 0.182
School 12 66.7 6 33.3 0.046a
Squint 0 0 18 100.0 <0.001a
Speech 8 44.4 10 55.6 0.505
Sp Ther 13 72.2 5 27.8 0.008a
Gest 15 83.3 3 16.7 <0.001a
Comm 7 38.9 11 61.1 0.182
Upper Limb 15 83.3 3 16.7 <0.001a
Tongue Mob 5 27.8 13 72.2 0.008a
Eye Mob 6 33.3 12 66.7 0.046a
Neuro 15 83.3 3 16.7 <0.001a
ORL 17 94.4 1 5.6 <0.001a
Abbreviations: astatiscally signiﬁcant; Amb, residence at the clinic; ADL, perform activities of daily living independently; Hand Sur, syndactyly surgery;
Eye Sur, eye surgery for strabismus; Palate Sur, palatoplasty; Misoprostol, use of misoprostol during pregnancy mentioned by the mother or guardian;
Under, speech understanding; Drugs, illicit drug use during pregnancy mentioned by the mother or guardian; Emiss, presence of emission—speech
issue; School, schooling; Squint, squint present; Speech, speech quality; Sp Ther, service of speech therapy; Gest, presence of mimic; Comm, presence
of communication; Upper Limb, malformation in upper limb; Tongue Mob, presence of tongue mobility; Eye Mob, presence of eye’s mobility; Neuro,
proven presence of neurologic changes; ORL, proven presence of otorhinolaryngology changes.
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pregnancy could present more severe neurologic manifesta-
tions or a greater number of associated complications and are
shown in ►Table 3. Neurologic changes were not evident in
these individuals (►Table 4). There were also no differences
for the speech and language difﬁculties.
Discussion
We correlated the data compiled for this population and data
found in the literature to study whether ingestion of miso-
prostol during pregnancy caused more severe disease or
manifestations different from that in subjects whosemothers
reported no intake.
Individuals whose mothers reported that they had taken
misoprostol (61.1%) did not show different manifestations
that those whose mothers did not report drug intake. Al-
though data that misoprostol can cause MS exist in the
literature,5–7 these refer to the usual manifestations of the
disease, such as strabismus and congenital clubfeet,7,8 and no
differences in language disorders and central nervous system
were reported, as was found in our study.
Our patients came from other places and institutions.
Three (16.7%) of these individuals came to our outpatient
clinic after consultation and assessment interview. Although
some references discussed different professionals’work with
these individuals,16 none of the other articles mentioned
long-term therapeutic monitoring.8 The references report
results from research conducted with these individuals,
with no record of visits to speciﬁc clinics such as ours for
this type of patient.
The use of misoprostol in our sample was presented as a
possible cause of MS in these individuals.5–7 In France,7 a
survey demonstrated that ingestion of misoprostol abortion
and other drugs during the seventh week of pregnancy can
cause the onset ofMS in the baby. These authorswarn that the
critical period is between the ﬁfth and eighth weeks of
gestation and therefore mothers should be advised about
the riskof ingestion of this drug. Unfortunately in our country,
even if they are warned, many women prefer to take the risk,
with the hope that the abortion is performed. We found no
evidence in the references of other events in mothers during
pregnancy, such as hypertension and diabetes, as were found
in our study.
The disease is characterized by lack of facial expression
(VII cranial nerve paralysis) and eye shift mobility (cranial
nerve VI).1–3,8 Bilateral facial palsy occurred in 83.3% of
individuals in this sample. Although this event may also be
unilateral themost frequently found is bilateral. According to
our observation in individuals who were already treated in
our clinic, the fact that the demonstration was bilateral does
not exclude the fact that one side may be better than the
other.
The most common manifestation accompanying facial
paralysis and lack of mobility of the eyes to the sides is the
occurrence of congenital clubfeet.6,8 Some cases also have
cleft palate.11 These manifestations have been described in
the literature, and the individuals evaluated in our outpatient
clinic corroborate these ﬁndings.
The most common complaint among mothers, after the
absence of facial movements, referred to feeding and
speech2,12,13; however, problems as understanding lan-
guage16 and changes in neurologic examinations, such as
calciﬁcations and vascular changes,10,17 were also discussed.
The occurrence on the difﬁculty of understanding language16
does not seem to be frequent; however, in our sample we
found 33.3% of mothers who complained about this in their
children. Among the data, we found that 3 subjects (16.7%)
manifested seizures changes, disorders, and vascular calciﬁ-
cations (p < 0.001). Some authors cite disorders and vascular
calciﬁcations as manifestations accompanying this
paralysis.10,18
Approximately 44.4% of our subjects had not yet begun
talking, due to early age and a slight delay in language
development. Thirteen individuals (72.2%) had sufﬁcient
tongue mobility for swallowing and speech. Only 5 (27.8%)
showed the expected changes of the disease, such the reali-
zation of bilabial consonants articulation at other places that
not lips and difﬁculty achieving the apical tongue sounds, as
mentioned by other authors.12,13
Most patients had been attending school regularly,17 and
the youngest has not attended because it was not convenient
for the parents.
We raised the hypothesis that the use of misoprostol could
aggravate the commonmanifestations of this disease, but our
isolated analysis of the results of individuals whose mothers
took Cytotec demonstrated no signiﬁcant differences. Some
authors did not follow the development of individuals whose
mothers ingested the drug and therefore cannot check if those
subjects had more severe manifestations than individuals
whose mothers did not use the drug.5–8
Table 3 Relationship between altered CNS and using misoprostol during pregnancy (p ¼ 0.914)
CNS Misoprostol Total
No Yes
n % n % n %
No 4 57.1 6 54.5 10 55.6
Yes 3 42.9 5 45.5 8 44.4
Total 7 38.9 11 61.1 18 100
Abbreviation: CNS, central nervous system.
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Since 1989 our services have been offered to individuals
with MS, including myofunctional stimulation, which after
some time presents some results (especially if the patient has
one side less affected than the other) and also encourages the
use of gestures, which serve as addition to communication.
However, the frequency of visits has grown in recent years
and individuals are coming earlier (4 months), suggesting
that the diagnosis is made earlier and referrals made more
objectively.
Conclusions
Individuals whose mothers took misoprostol during preg-
nancy showed manifestations similar to those of individuals
whosemothers did not report drug intake, in agreement with
the data found in the literature. There was a large contingent
of women who took misoprostol without knowing its terato-
genic action.
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